Somatic hypermutation of immunoglobulin genes

Annual Review of Immunology
S D Wagner, Michael S Neuberger

Abstract

The relationship between somatic hypermutation and affinity maturation in the mouse is delineated. Recent work on the anatomical and cellular site of this process is surveyed. The molecular characteristics of somatic hypermutation are described in terms of the region mutated and the distinctive patterns of nucleotide changes that are observed. The results of experiments utilizing transgenic mice to find out the minimum cis-acting sequences required to recruit hypermutation are summarized. The hypothesis that V gene sequences have evolved in order to target mutation to certain sites but not others is discussed. The use that different species make of somatic hypermutation to generate either the primary or secondary B cell repertoire is considered. Possible molecular mechanisms for the hypermutation process and future goals of research are outlined.

References

Jul 11, 1992·The Journal of Experimental Medicine·J HackettU Storb
Aug 22, 1991·Proceedings. Biological Sciences·Z AgurI Meilijson
Jun 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·A UmarP J Gearhart
Aug 8, 1991·Nature·J Foote, C Milstein
Sep 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·N MotoyamaT Azuma
Dec 5, 1991·Nature·I MacLennan
Jun 1, 1990·European Journal of Immunology·M J SharpeC Milstein
Oct 1, 1990·Molecular and Cellular Biology·G W BothE J Steele
Jan 1, 1989·Annual Review of Biochemistry·L J Wysocki, M L Gefter
Aug 1, 1988·The Journal of Experimental Medicine·S LevyR Levy
Mar 1, 1988·The Journal of Experimental Medicine·N C ChienM D Scharff
Apr 1, 1987·Immunological Reviews·C Berek, C Milstein
Mar 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·L WysockiM L Gefter
Jan 1, 1987·Genetics·G B GoldingB W Glickman
Oct 1, 1987·Biochemical Society Transactions·C Milstein
Jan 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·M WablC Steinberg
Jun 1, 1985·The Journal of Experimental Medicine·M E Boersch-SupanT Imanishi-Kari
May 18, 1973·Science·R R Porter
Dec 1, 1967·The Journal of Experimental Medicine·L A Steiner, H N Eisen
Jan 1, 1969·Advances in Immunology·G W Siskind, B Benacerraf
Jun 1, 1965·Proceedings of the National Academy of Sciences of the United States of America·N Hilschmann, L C Craig
Jul 16, 1966·Nature·S Brenner, C Milstein
May 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·D McKeanM Weigert
Jun 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·P J Gearhart, D F Bogenhagen
Apr 14, 1983·Nature·S Tonegawa

❮ Previous
Next ❯

Citations

May 4, 2005·Trends in Immunology·Antonio UccelliVito Pistoia
Jun 5, 2002·Molecular Immunology·Hermann J Girschick, Peter E Lipsky
Jun 20, 2002·Veterinary Immunology and Immunopathology·A KaushikS S Saini
Jun 17, 2000·Trends in Neurosciences·J J Archelos, H P Hartung
Mar 30, 1999·Mutation Research·R S HarrisN Maizels
Dec 22, 2007·Nature Reviews. Immunology·Ulf Klein, Riccardo Dalla-Favera
Jun 17, 1998·Proceedings of the National Academy of Sciences of the United States of America·G Kelsoe
Jun 11, 2003·The Journal of Experimental Medicine·Yuichi HaradaKazumichi Kuroda
Jun 30, 2009·International Immunology·Louise S MathesonMarianne Brüggemann
Mar 6, 2003·Vox Sanguinis·S J Urbaniak
May 29, 1998·Immunological Reviews·Q KongN Maizels
May 29, 1998·Immunological Reviews·N S GreenM D Scharff
May 29, 1998·Immunological Reviews·U KleinR Küppers
Jul 21, 1998·Annals of the New York Academy of Sciences·S Ragheb, R P Lisak
Nov 13, 2004·Clinical and Diagnostic Laboratory Immunology·G R McLeanA K Junker
Nov 2, 2001·Molecular and Cellular Biology·Y ZhangZ Wang
Jun 5, 2002·Annual Review of Biochemistry·Martin Gellert
Jun 8, 1999·Annual Review of Immunology·G W LitmanJ P Rast
Apr 1, 1997·The Journal of Clinical Investigation·S J FosterP E Lipsky
Feb 29, 2008·Immunome Research·Joseph M Volpe, Thomas B Kepler
May 30, 2013·PloS One·Stefanie WaltherUlrike S Diesterbeck
May 25, 2006·International Journal of Hematology·Kazuo Kinoshita, Taichiro Nonaka
Oct 9, 1998·Clinical and Experimental Immunology·J RidingsH Zola
May 13, 1997·Proceedings of the National Academy of Sciences of the United States of America·M M LinM D Scharff
Feb 3, 2000·Proceedings of the National Academy of Sciences of the United States of America·G EspositoK Rajewsky
Dec 14, 2007·Proceedings of the National Academy of Sciences of the United States of America·Weiling ChenHong Jiang
Mar 16, 2005·Proceedings of the National Academy of Sciences of the United States of America·Ai KotaniTasuku Honjo
Aug 10, 2005·Proceedings of the National Academy of Sciences of the United States of America·Diana RonaiMatthew D Scharff

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic

Related Concepts

Related Feeds

Antibody Engineering

Antibody engineering technologies are constantly advancing to improve the clinical effectiveness of monoclonal and bispecific antibodies. Discover the latest research on Antibody Engineering here.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Antibody Repertoire Diversity

Antibody repertoire diversity and its role during natural infection is a prerequisite for molecular and structural elucidation of functionally protective immunity. Discover the latest insights into antibody diversity here.